Alexandria Hammond
Stock Analyst at B of A Securities
(0.35)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AKRO Akero Therapeutics | Maintains: Strong Buy | 63 64 | 48.32 | 32.45% | 4 | May 27, 2025 | |
REGN Regeneron Pharmaceut... | Initiates Coverage On: Outperform | 1150 | 546.18 | 110.55% | 1 | Nov 15, 2024 | |
PFE Pfizer | Initiates Coverage On: Underperform | 25 | 24.61 | 1.58% | 1 | Nov 15, 2024 | |
MRNA Moderna | Initiates Coverage On: Underperform | 40 | 25.48 | 56.99% | 1 | Nov 15, 2024 | |
MRK Merck & Co | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 1000 | 635.48 | 57.36% | 1 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 190 | 173.87 | 9.28% | 1 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 110 | 120.57 | -8.77% | 1 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 205 | 198.62 | 3.21% | 1 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 150 | 349.43 | -57.07% | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 30 | 8.76 | 242.47% | 1 | Apr 22, 2024 |